Psychemedics Corp
NASDAQ:PMD
Psychemedics Corp
Long-Term Debt
Psychemedics Corp
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Psychemedics Corp
NASDAQ:PMD
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Long-Term Debt
$9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Long-Term Debt
$3.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
0%
|
|
CVS Health Corp
NYSE:CVS
|
Long-Term Debt
$57.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
16%
|
|
Cigna Corp
NYSE:CI
|
Long-Term Debt
$31.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Long-Term Debt
$3.1B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
1%
|
See Also
What is Psychemedics Corp's Long-Term Debt?
Long-Term Debt
0
USD
Based on the financial report for Mar 31, 2024, Psychemedics Corp's Long-Term Debt amounts to 0 USD.